Upcoming- DPS Group Participation in an ISPE Boston Area Chapter Panel Discussion
John Dougherty, principal process engineer at DPS Group, will participate in an ISPE Boston Area Chapter panel discussion on “Designing, Building & Operating Manufacturing Facilities for Novel Therapeutics” on December 6, 2018, moderated by Jeff Kent, process engineer at DPS Group. Dougherty will be joined by panelist, Lance Weed, Principal Consultant, and others to be announced.
Sponsored by the ISPE Boston Chapter, the education session will focus on the design of manufacturing facilities for the production of novel therapeutics, which requires careful planning and consideration of a myriad of factors such as throughput, biosafety level, product segregation and contamination control, regulatory environment, time to market, and tech transfer challenges. It is a complex mix of elements, and requires a project team that can move quickly and effectively to de-risk the investment and meet market demand. Recently, many firms have embarked on ambitious program to bring manufacturing capacity for gene and cell therapies online to meet demand for novel therapeutics.
The education session will cover planning, design, quality/regulatory considerations, and technology platforms utilized in the design of manufacturing facilities for the production of novel therapeutics.
Where
Novartis Institutes for Biomedical Research 250 Massachusetts Avenue Cambridge, MA 02139When
Thursday, December 6, 2018 5:30 pm to 8:30 pm To register for this event, click hereWho
John Dougherty, Principal Process Engineer, DPS Group

Jeff Kent, Process Engineer, DPS Group
